Free tool
FAERS Monitor: Cyclophosphamide
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 212501 or its brand name (Cyclophosphamide, Cyclophosphamide). Reports on generic versions are filed under their own applications.
Reports
179,391
Serious
172,655
96% of reports
Hospitalization
64,821
Death reported
36,268
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use16,826
- febrile neutropenia14,787
- drug ineffective10,788
- neutropenia10,780
- pyrexia9,368
- disease progression8,229
- pneumonia6,779
- thrombocytopenia6,679
- product use in unapproved indication6,563
- nausea6,354
- anaemia6,286
- sepsis5,803
- diarrhoea5,568
- death5,287
- vomiting5,000
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,541 |
| 2005 | 1,760 |
| 2006 | 1,662 |
| 2007 | 1,990 |
| 2008 | 2,643 |
| 2009 | 3,104 |
| 2010 | 3,472 |
| 2011 | 5,665 |
| 2012 | 5,198 |
| 2013 | 3,764 |
| 2014 | 4,002 |
| 2015 | 5,802 |
| 2016 | 5,819 |
| 2017 | 7,870 |
| 2018 | 11,680 |
| 2019 | 12,218 |
| 2020 | 12,590 |
| 2021 | 12,754 |
| 2022 | 15,807 |
| 2023 | 17,132 |
| 2024 | 17,177 |
| 2025 | 15,538 |
| 2026 | 10,200 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,874,768 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 14,787 | 33.3 | 32.8 | 361,655 |
| neutropeniaSignal | 10,780 | 10.0 | 9.8 | 81,008 |
| disease progressionSignal | 8,229 | 8.7 | 8.5 | 52,382 |
| thrombocytopeniaSignal | 6,679 | 7.4 | 7.2 | 34,842 |
| sepsisSignal | 5,803 | 6.4 | 6.2 | 25,083 |
| anaemiaSignal | 6,286 | 4.0 | 3.9 | 13,581 |
| pyrexiaSignal | 9,368 | 3.2 | 3.2 | 14,305 |
| product use in unapproved indicationSignal | 6,563 | 3.2 | 3.1 | 9,555 |
| pneumoniaSignal | 6,779 | 2.5 | 2.4 | 5,986 |
| off label useSignal | 16,826 | 2.3 | 2.2 | 12,338 |
| vomiting | 5,000 | 1.2 | 1.2 | 252 |
| diarrhoea | 5,568 | 1.0 | 1.0 | 1 |
| drug ineffective | 10,788 | 1.0 | 0.9 | 20 |
| nausea | 6,354 | 0.9 | 0.9 | 24 |
| death | 5,287 | 0.7 | 0.7 | 608 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.